JAMP ALPRAZOLAM 0.5 MG — DIN 02397048
ALPRAZOLAM : 0.5 MG · JAMP PHARMA CORPORATION · TABLET · wholesale supply in Canada
Health Canada status: APPROVED
What is JAMP ALPRAZOLAM?
JAMP ALPRAZOLAM 0.5 MG contains ALPRAZOLAM : 0.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02397048, held by JAMP PHARMA CORPORATION, supplied as TABLET for ORAL administration. Health Canada currently lists it as approved, status dated 15-Sep-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
What is JAMP ALPRAZOLAM used for?
JAMP Alprazolam (alprazolam) is indicated for the management of Anxiety Disorders or the short - term symptomatic relief of symptoms of excessive anxiety. JAMP Alprazolam is indicated for the treatment of Generalized Anxiety Disorder (GAD). JAMP Alprazolam is also indicated for the management of Panic Disorder with or without Agoraphobia.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Alprazolam cost around the world?
Alprazolam is listed on 18 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Spain | PVP con IVA (public price) | 71 | 71 | EUR███.██ |
| Brazil | preco fabrica (ex-factory ceiling) | 5 | 60 | BRL███.██ |
| United States | acquisition | 4 | 60 | USD███.██ |
| Sweden | AIP (pharmacy purchase price) | 6 | 42 | SEK███.██ |
| South Africa | single exit price | 30 | 41 | ZAR███.██ |
| Czechia | max producer price (ex-factory) | 7 | 34 | CZK███.██ |
| Luxembourg | reimbursement | 27 | 27 | EUR███.██ |
| Romania | max producer price | 15 | 21 | RON███.██ |
| Hungary | producer price (ex-factory) | 12 | 16 | HUF███.██ |
| Slovakia | categorised final price | 15 | 15 | EUR███.██ |
| Greece | producer price (ex-factory) | 9 | 9 | EUR███.██ |
| Austria | KVP (Kassenverkaufspreis) | 4 | 8 | EUR███.██ |
| Saudi Arabia | public | 6 | 8 | SAR███.██ |
| Bahrain | retail (max) | 1 | 7 | BHD███.██ |
| United Arab Emirates | public | 3 | 5 | AED███.██ |
| Australia | ex-manufacturer | 5 | 5 | AUD███.██ |
| Norway | max AUP (pharmacy retail) | 1 | 4 | NOK███.██ |
| Morocco | PPV (public price) | 2 | 3 | MAD███.██ |
436 pack listings across 223 brand entries and 16 price bases, refreshed 08 Sep 2026. Ranges span every Alprazolam pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Alprazolam in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
12 holders have a Canadian DIN containing Alprazolam, across 50 DINs, of which 13 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| APOTEX INC | 4 | 4 | APO-ALPRAZ, APO-ALPRAZ TS | Sourceable in Canada |
| BGP PHARMA ULC | 4 | 4 | XANAX, XANAX TS | Sourceable in Canada |
| PRO DOC LIMITEE | 4 | 3 | PRO-ALPRAZOLAM, PRO-ALPRAZOLAM TS | Sourceable in Canada |
| TEVA CANADA LIMITED | 4 | 2 | NTP-ALPRAZOLAM, TEVA-ALPRAZOLAM | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 12 | 0 | ALPRAZOLAM, JAMP ALPRAZOLAM, JAMP-ALPRAZOLAM | No marketed DIN |
| LABORATOIRE RIVA INC. | 6 | 0 | RIVA-ALPRAZOLAM, RIVA-ALPRAZOLAM 0.25 MG, RIVA-ALPRAZOLAM 0.5 MG | No marketed DIN |
| MYLAN PHARMACEUTICALS ULC | 4 | 0 | MYLAN-ALPRAZOLAM | No marketed DIN |
| NATCO PHARMA (CANADA) INC | 4 | 0 | NAT-ALPRAZOLAM | No marketed DIN |
| NU-PHARM INC | 2 | 0 | NU-ALPRAZ TAB 0.25MG, NU-ALPRAZ TAB 0.5MG | No marketed DIN |
| PREMPHARM INC | 2 | 0 | ALPRAZOLAM TABLETS 0.25, ALPRAZOLAM TABLETS 0.5MG | No marketed DIN |
| RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | 2 | 0 | RATIO-ALPRAZOLAM | No marketed DIN |
| SANIS HEALTH INC | 2 | 0 | ALPRAZOLAM | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 0.5 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | null |
| Storage | null |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Alprazolam |
|---|---|
| ATC code | N05BA12 |
| AHFS class | 28:24.08 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02397048 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2397048 |
| Brand name | JAMP ALPRAZOLAM |
| Generic / active ingredient | ALPRAZOLAM : 0.5 MG |
| Market authorization holder | JAMP PHARMA CORPORATION |
| Health Canada schedule | TARGETED SUBSTANCES (CDSA IV) |
| ATC code | N05BA12 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05BA |
| Current status | APPROVED |
| Status date | 15-Sep-2020 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
13 of 50 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-ALPRAZ | 0.5 MG | TABLET | APOTEX INC | MARKETED | 00865400 |
| APO-ALPRAZ | 1 MG | TABLET | APOTEX INC | MARKETED | 02243611 |
| APO-ALPRAZ | 0.25 MG | TABLET | APOTEX INC | MARKETED | 00865397 |
| APO-ALPRAZ TS | 2 MG | TABLET | APOTEX INC | MARKETED | 02243612 |
| PRO-ALPRAZOLAM | 1 MG | TABLET | PRO DOC LIMITEE | MARKETED | 02248706 |
| PRO-ALPRAZOLAM | 0.25 MG | TABLET | PRO DOC LIMITEE | MARKETED | 01908189 |
| PRO-ALPRAZOLAM | 0.5 MG | TABLET | PRO DOC LIMITEE | MARKETED | 01908170 |
| TEVA-ALPRAZOLAM | 0.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 01913492 |
| TEVA-ALPRAZOLAM | 0.25 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 01913484 |
| XANAX | 0.25 MG | TABLET | BGP PHARMA ULC | MARKETED | 00548359 |
2 · Same class — other molecules in ATC N05BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Lorazepam | APO-LORAZEPAM · ATIVAN · ATIVAN INJ 4MG/ML · ATIVAN INJECTION LIQ 4MG/ML · ATIVAN SUBL TAB 0.5MG · ATIVAN SUBL TAB 1MG · ATIVAN TAB 0.5MG · ATIVAN TAB 1MG · ATIVAN TAB 2MG · DOM-LORAZEPAM · LORAZEPAM · LORAZEPAM INJECTION USP · LORAZEPAM INJECTION, USP · LORAZEPAM SUBLINGUAL · NTP-LORAZEPAM · NU-LORAZ TAB 0.5MG · NU-LORAZ TAB 1MG · NU-LORAZ TAB 2MG · PHL-LORAZEPAM · PMS-LORAZEPAM · PRO-LORAZEPAM · RIVA-LORAZEPAM 0.5 MG TABLETS · RIVA-LORAZEPAM 1 MG TABLETS · RIVA-LORAZEPAM 2MG TABLETS · TEVA-LORAZEPAM | 53 | 17 | Yes |
| Alprazolam | ALPRAZOLAM · ALPRAZOLAM TABLETS 0.25 · ALPRAZOLAM TABLETS 0.5MG · APO-ALPRAZ · APO-ALPRAZ TS · JAMP ALPRAZOLAM · JAMP-ALPRAZOLAM · MYLAN-ALPRAZOLAM · NAT-ALPRAZOLAM · NTP-ALPRAZOLAM · NU-ALPRAZ TAB 0.25MG · NU-ALPRAZ TAB 0.5MG · PRO-ALPRAZOLAM · PRO-ALPRAZOLAM TS · RATIO-ALPRAZOLAM · RIVA-ALPRAZOLAM · RIVA-ALPRAZOLAM 0.25 MG · RIVA-ALPRAZOLAM 0.5 MG · TEVA-ALPRAZOLAM · XANAX · XANAX TS | 50 | 13 | Yes |
| Oxazepam | APO-OXAZEPAM · BIO-OXAZEPAM · NOVOXAPAM TAB 10MG · NOVOXAPAM TAB 15MG · NOVOXAPAM TAB 30MG · OXAZEPAM 10MG TABLETS · OXAZEPAM 15MG TABLETS · OXAZEPAM 30MG TABLETS · OXAZEPAM TABLETS 15MG · OXAZEPAM TABLETS 30MG · OXPAM · PMS-OXAZEPAM TAB 10MG · PMS-OXAZEPAM TAB 15MG · PMS-OXAZEPAM TAB 30MG · PRO-OXAZEPAM · RIVA-OXAZEPAM · SERAX TAB 15MG · SERAX TAB 30MG · SERAX TABLETS 10MG · SERAX TABLETS 15MG · SERAX TABLETS 30MG | 31 | 9 | Yes |
| Diazepam | BIO-DIAZEPAM · DIASTAT · DIAZEMULS · DIAZEPAM · DIAZEPAM 10MG TABLETS · DIAZEPAM 10TAB 10MG · DIAZEPAM 2MG TABLETS · DIAZEPAM 2TAB 2MG · DIAZEPAM 5 TAB · DIAZEPAM 5MG TABLETS · DIAZEPAM AUTOINJECTOR · DIAZEPAM INJECTION SDZ · DIAZEPAM INJECTION USP · E PAM TAB 10MG · E PAM TAB 2MG · E PAM TAB 5MG · MEVAL 2 · MEVAL 5 · NOVO-DIPAM TAB 10MG · NOVO-DIPAM TAB 2MG · NOVO-DIPAM TAB 5MG · PMS-DIAZEPAM · PMS-DIAZEPAM SOLUTION 1MG/ML · VALIUM · VALIUM 10 TAB · VALIUM INJ ROCHE 5MG/ML · VIVOL | 38 | 8 | Yes |
| Bromazepam | ALTI-BROMAZEPAM 1.5MG TABLETS · ALTI-BROMAZEPAM 3MG TABLETS · ALTI-BROMAZEPAM 6MG TABLETS · APO-BROMAZEPAM · BROMAZEPAM · BROMAZEPAM-1.5 - TAB 1.5MG · BROMAZEPAM-3 - TAB 3MG · BROMAZEPAM-6 - TAB 6MG · GEN-BROMAZEPAM - TAB 3MG · GEN-BROMAZEPAM - TAB 6MG · LECTOPAM TAB 1.5MG · LECTOPAM TAB 3MG · LECTOPAM TAB 6MG · MYLAN-BROMAZEPAM · PENTA-BROMAZEPAM TABLETS · RIVA-BROMAZEPAM 3 MG · RIVA-BROMAZEPAM 6 MG · TEVA-BROMAZEPAM | 24 | 4 | Yes |
| Clorazepate Potassium | CLORAZEPATE · NOVO-CLOPATE CAP 15MG · NOVO-CLOPATE CAP 3.75MG · NOVO-CLOPATE CAP 7.5MG · TRANXENE CAP 15MG · TRANXENE CAP 3.75MG · TRANXENE CAP 7.5MG | 9 | 3 | Yes |
| Clobazam | APO-CLOBAZAM · CLOBAZAM-10 · DOM-CLOBAZAM · FRISIUM TAB 10MG · FRISIUM TABLET 10MG · FRISIUM TABLETS 10MG · NTP-CLOBAZAM · PMS-CLOBAZAM · RATIO-CLOBAZAM · TEVA-CLOBAZAM | 10 | 2 | Yes |
| Chlordiazepoxide | CHLORDIAZEPOXIDE · CHLORDIAZEPOXIDE CAP 10MG · CHLORDIAZEPOXIDE CAP 5MG · CHLORDIAZEPOXYDE 25 CAP · CHLORDIAZEPOXYDE CAP 10MG · CHLORDIAZEPOXYDE HCL CAP 25MG · CORAX CAP 10MG · CORAX CAP 25MG · CORAX CAP 5MG · MEDILIUM CAP 10 10MG · MEDILIUM CAP 5MG · NOVO-POXIDE 10MG · NOVO-POXIDE 25MG · NOVO-POXIDE 5MG | 16 | 1 | Yes |
| Ketazolam | LOFTRAN CAP 30MG | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N05B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N05BE | Buspirone | 25 | 7 |
| N05BB | Hydroxyzine | 29 | 5 |
| N05BC | Meprobamate | 7 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is JAMP ALPRAZOLAM called?
The same molecule, Alprazolam, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| ALPRAZOLAM | Latin | Brazil |
| XANAX | Latin | Bahrain, Czechia, Morocco |
| Xanor® | Latin | Sweden |
| Alprazolam Grindeks | Latin | Czechia, Sweden |
| Alprazolam Krka d.d. | Latin | Sweden |
| FRONTAL | Latin | Brazil |
| TRANQUINAL | Latin | Brazil |
| Alprazolam Krka | Latin | Sweden |
| Alprazolam Orion | Latin | Sweden |
| FRONTIN | Latin | Czechia |
| XANAX SR | Latin | Czechia |
| Xanor® Depot | Latin | Sweden |
| APRAZ | Latin | Brazil |
| Xanor | Latin | Norway |
| ALPROX | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.